Science ❯ Medical Research ❯ Vaccine Development ❯ Clinical Trials

Placebo-Controlled Trials

FDA Approves LP.8.1 COVID Boosters, Limits Routine Use to Seniors and High-Risk Patients

Uncertainty over CDC guidance now clouds insurance coverage.

FDA Shifts COVID-19 Vaccine Policy to Focus on High-Risk Groups